Authors: Copelan, EA Bechtel, TP Avalos, BR Elder, PJ Ezzone, SA Scholl, MD Penza, SL

Citation: Ea. Copelan et al., Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation, BONE MAR TR, 27(11), 2001, pp. 1121-1124

Authors: Copelan, EA Penza, SL Theil, KS Elder, PJ Bechtel, TP Tighe, MB Ezzone, SA Scholl, MD Belt, PS Young, DC Avalos, BR

Citation: Ea. Copelan et al., The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy, BONE MAR TR, 26(10), 2000, pp. 1037-1043

Authors: Copelan, EA Penza, SL Elder, PJ Ezzone, SA Scholl, MD Bechtel, TP Belt, PS Avalos, BR

Citation: Ea. Copelan et al., Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation, BONE MAR TR, 25(12), 2000, pp. 1219-1222

Authors: Copelan, EA Penza, SL Pohlman, B Avalos, BR Goormastic, M Andresen, SW Kalaycio, M Bechtel, TP Scholl, MD Elder, PJ Ezzone, SA O'Donnell, LC Tighe, MB Risley, GL Young, DC Bolwell, BJ

Citation: Ea. Copelan et al., Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma, BONE MAR TR, 25(12), 2000, pp. 1243-1248

Authors: Penza, SL Copelan, EA

Citation: Sl. Penza et Ea. Copelan, Should all adult patients with acute lymphoblastic leukemia in first remission undergo allogeneic bone marrow transplantation?, CUR CLIN ON, 2000, pp. 95-105